Loading
Latest filing published 11 Jan 2023 for Imago BioSciences, Inc., €4.7M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Amy E. Tapper in Imago BioSciences, Inc. Over a trading history stretching from 12 January 2022 to 11 January 2023, the count stands at 10 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 11 January 2023: a transaction of €4.7M, in Imago BioSciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations